byiShook Opinion
Dec 13, 2024 - 19:50
Neurocrine Biosciences won Food and Drug Administration approval late Friday for the first new treatment for an adrenal disease in decades. The post Neurocrine Wins FDA Approval For Genetic Disorder Drug appeared first on Investor's Business Daily.
Neurocrine Biosciences won Food and Drug Administration approval late Friday for the first new treatment for an adrenal disease in decades.
The post Neurocrine Wins FDA Approval For Genetic Disorder Drug appeared first on Investor's Business Daily.